The impact of pediatric hematopoietic stem cell transplant timing and psychosocial factors on family and caregiver adjustment

被引:6
|
作者
Chardon, Marie L. [1 ]
Canter, Kimberly S. [2 ,3 ]
Pai, Ahna L. H. [1 ,4 ]
Peugh, James L. [1 ,4 ]
Madan-Swain, Avi [5 ]
Vega, Gabriela [2 ]
Joffe, Naomi E. [1 ,4 ]
Kazak, Anne E. [2 ,3 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave,MLC 7039, Cincinnati, OH 45229 USA
[2] Nemours Childrens Hlth Syst, Nemours Ctr Healthcare Delivery Sci, Orlando, FL USA
[3] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA
[4] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH USA
[5] Univ Alabama Birmingham, Div Pediat Hematol & Oncol, Birmingham, AL USA
关键词
family adjustment; hematology; oncology; pediatric; stem cell transplantation; QUALITY-OF-LIFE; PARENTS; CHILDREN; SURVIVORS; DISTRESS; SIBLINGS; PATTERNS; MOTHERS; SCALE; SCT;
D O I
10.1002/pbc.28552
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The impact of pediatric hematopoietic stem cell transplant (HCT) on family functioning varies, but little is known about how the timing of HCT in children's treatment course contributes to this variability. This study examines how preexisting child, sibling, and family problems, the length of time between diagnosis to HCT, and children's age at HCT are associated with family and caregiver functioning. Procedure Caregivers (n = 140) of children (<= 18 years old) scheduled to undergo their first HCT completed the Psychological Assessment Tool-HCT and the Impact on Family Scale. Treatment information was extracted from electronic medical records. A bootstrapped multivariate path analysis was used to test the hypotheses. Results More preexisting family problems related to greater caregiver perceived negative impact of their child's HCT across family and caregiver functioning domains. Less time between diagnosis and HCT was associated with greater caregiver personal strain, particularly for those with younger children undergoing HCT. Younger child age at HCT was also associated with a larger negative impact on family social functioning. Conclusions Families with preexisting problems are the most at-risk for experiencing negative impacts related to their child's HCT. The timing of a child's HCT within their treatment course and the child's age during HCT may impact families' social functioning and caregiver adjustment. Screening families for preexisting family problems, particularly for families with young children or who are abruptly learning of their child's need for an HCT, may assist providers in identifying families who would benefit from earlier or more intensive psychosocial support.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] FLUCONAZOLE PROPHYLAXIS FOR PEDIATRIC ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT
    Jain, Amit
    Patil, Rajesh
    Sharma, Ratna
    Kini, Pranoti
    Walawalkar, Ashutosh
    Chiwarkar, Pranoti
    Manglani, Mamta
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 433 - 433
  • [42] Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient
    Munchel, Ashley
    Chen, Allen
    Symons, Heather
    CLINICAL PEDIATRIC EMERGENCY MEDICINE, 2011, 12 (03) : 233 - 244
  • [43] PEDIATRIC POST HEMATOPOIETIC STEM CELL TRANSPLANT NEUTROPHIL FUNCTION
    Kent, Michael
    Bock, Ashley
    Kelher, Marguerite
    Silliman, Christopher
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S101 - S101
  • [44] TRACHEOSTOMY IN PEDIATRIC ONCOLOGY AND HEMATOPOIETIC STEM CELL TRANSPLANT POPULATIONS
    Salem, Sinead Murphy
    Perez, Jennifer
    Duncan, Christine
    Staffa, Steven
    Graham, Robert
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 472 - 472
  • [45] Cytomegalovirus Treatment in Pediatric Hematopoietic Stem Cell Transplant Patients
    Wattles, Bethany A.
    Kim, Abby J.
    Cheerva, Alexandra C.
    Lucas, Kenneth G.
    Elder, Joshua J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (04) : 241 - 248
  • [46] Fever and neutropenia in pediatric hematopoietic stem cell transplant patients
    CA Mullen
    J Nair
    S Sandesh
    KW Chan
    Bone Marrow Transplantation, 2000, 25 : 59 - 65
  • [47] BK nephropathy in pediatric hematopoietic stem cell transplant recipients
    Verghese, Priya S.
    Finn, Laura S.
    Englund, Janet A.
    Sanders, Jean E.
    Hingorani, Sangeeta R.
    PEDIATRIC TRANSPLANTATION, 2009, 13 (07) : 913 - 918
  • [48] HYPERTENSION IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
    Owens, C.
    Ashraf, K.
    Chong, D.
    Stesco, N.
    Depuis, L.
    Fernandez, C.
    Gassas, A.
    Nathan, P.
    Doyle, J.
    Schechter-Finkelstein, T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S267 - S267
  • [49] BK nephropathy in pediatric hematopoietic stem cell transplant.
    Verghese, Priya
    Finn, Laura
    Englund, Janet
    Sanders, Jean
    Hingorani, Sangeeta
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 419 - 420
  • [50] Pulmonary Screening of Pediatric Hematopoietic Stem Cell Transplant Patients
    Towe, C.
    Gloude, N.
    El-Bietar, J.
    Grimley, M.
    Walkup, L.
    Woods, J. C.
    Myers, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197